Literature DB >> 21740481

Systemic cytokine levels and subsequent risk of gastric cancer in Chinese Women.

Hui-Lee Wong1, Charles S Rabkin, Xiao-Ou Shu, Ruth M Pfeiffer, Qiuyin Cai, Bu-Tian Ji, Gong Yang, Hong-Lan Li, Nathaniel Rothman, Yu-Tang Gao, Wei Zheng, Wong-Ho Chow.   

Abstract

Although control of the host cytokine network is known to influence gastric cancer susceptibility, the specific inflammatory responses in gastric carcinogenesis remain unclear. We prospectively examined the relationships between gastric cancer risk and plasma levels of interleukin (IL)-1β, IL-6, IL-8 and tumor necrosis factor (TNF)-α in a nested case control study within The Shanghai Women's Health Study. Two controls were matched to each case on the basis of age, menopausal status, and sample collection parameters. The associations between gastric cancer risk and tertiles of cytokine levels were estimated by odds ratios (OR) and 95% confidence intervals (CI) from conditional logistic regression, adjusting for education. During a median follow-up period of 4 years (range 0.1-8 years), 141 women developed gastric cancer and were matched to 282 cancer-free study participants. Elevated levels of plasma IL-6 were associated with an increased risk of gastric cancer (P(trend) = 0.04). Risk increased 70% (OR = 1.7; 95% CI 1.0, 3.0) for women in the highest tertile (>4 pg/mL) of IL-6 compared with those in the lowest tertile (<1.8 pg/mL). The association between gastric cancer risk and IL-6 was stronger after 4 years of follow-up (OR = 2.6 [95% CI 1.0, 6.7] for highest versus lowest tertile) compared with an OR of 1.4 (95% CI 0.7, 2.9) for those diagnosed within 1-4 years of follow-up. No associations were observed with the other pro-inflammatory cytokines examined, namely IL-1β, IL-8, and TNF-α. Systemic plasma IL-6 levels may inform long-term gastric cancer risk. This novel finding awaits confirmation in future studies with sequential plasma collection.
© 2011 Japanese Cancer Association and this article is a US Government work and is in the public domain in the USA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21740481      PMCID: PMC3349461          DOI: 10.1111/j.1349-7006.2011.02033.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  28 in total

Review 1.  Helicobacter pylori and gastrointestinal tract adenocarcinomas.

Authors:  Richard M Peek; Martin J Blaser
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

2.  Interleukin-1 polymorphisms associated with increased risk of gastric cancer.

Authors:  E M El-Omar; M Carrington; W H Chow; K E McColl; J H Bream; H A Young; J Herrera; J Lissowska; C C Yuan; N Rothman; G Lanyon; M Martin; J F Fraumeni; C S Rabkin
Journal:  Nature       Date:  2000-03-23       Impact factor: 49.962

3.  Circulating levels of interleukin-10 and interleukin-6 in gastric and colon cancer patients before and after surgery: relationship with radicality and outcome.

Authors:  Gennaro Galizia; Eva Lieto; Ferdinando De Vita; Ciro Romano; Michele Orditura; Paolo Castellano; Vincenzo Imperatore; Stefania Infusino; Giuseppe Catalano; Carlo Pignatelli
Journal:  J Interferon Cytokine Res       Date:  2002-04       Impact factor: 2.607

4.  Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis.

Authors:  S F Shariat; B Andrews; M W Kattan; J Kim; T M Wheeler; K M Slawin
Journal:  Urology       Date:  2001-12       Impact factor: 2.649

5.  Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator.

Authors:  F De Vita; C Romano; M Orditura; G Galizia; E Martinelli; E Lieto; G Catalano
Journal:  J Interferon Cytokine Res       Date:  2001-01       Impact factor: 2.607

6.  Serum interleukin-6 levels reflect the disease status of colorectal cancer.

Authors:  Yuan-Chang Chung; Ya-Fen Chang
Journal:  J Surg Oncol       Date:  2003-08       Impact factor: 3.454

Review 7.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

8.  C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer.

Authors:  Nevin Ilhan; Necip Ilhan; Yavuz Ilhan; Handan Akbulut; Mehmet Kucuksu
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

9.  Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice.

Authors:  Niall C Tebbutt; Andrew S Giraud; Melissa Inglese; Brendan Jenkins; Paul Waring; Fiona J Clay; Sina Malki; Barbara M Alderman; Dianne Grail; Frédéric Hollande; Joan K Heath; Matthias Ernst
Journal:  Nat Med       Date:  2002-09-09       Impact factor: 53.440

10.  Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor.

Authors:  H K Kim; K S Song; Y S Park; Y H Kang; Y J Lee; K R Lee; H K Kim; K W Ryu; J M Bae; S Kim
Journal:  Eur J Cancer       Date:  2003-01       Impact factor: 9.162

View more
  11 in total

1.  Circulating cytokines and gastric cancer risk.

Authors:  Meira Epplein; Yong-Bing Xiang; Qiuyin Cai; Richard M Peek; Honglan Li; Pelayo Correa; Jing Gao; Jie Wu; Angelika Michel; Michael Pawlita; Wei Zheng; Xiao-Ou Shu
Journal:  Cancer Causes Control       Date:  2013-09-20       Impact factor: 2.506

2.  Using Immune Marker Panels to Evaluate the Role of Inflammation in Cancer: Summary of an NCI-sponsored Workshop.

Authors:  Danielle M Carrick; Anil K Chaturvedi; Meredith S Shiels; Rao L Divi; Kelly K Filipski; Elizabeth F Hebert; Mukesh Verma; Allan Hildesheim
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-06-24       Impact factor: 4.254

3.  Validation of a Blood Biomarker for Identification of Individuals at High Risk for Gastric Cancer.

Authors:  Meira Epplein; Wei-Cheng You; Julia Butt; Yang Zhang; Laura H Hendrix; Christian C Abnet; Gwen Murphy; Wei Zheng; Xiao-Ou Shu; Shoichiro Tsugane; You-Lin Qiao; Philip R Taylor; Taichi Shimazu; Keun-Young Yoo; Sue K Park; Jeongseon Kim; Sun Ha Jee; Tim Waterboer; Michael Pawlita; Kai-Feng Pan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-08-29       Impact factor: 4.254

4.  Helicobacter pylori blood biomarker for gastric cancer risk in East Asia.

Authors:  Hui Cai; Fei Ye; Angelika Michel; Gwen Murphy; Shizuka Sasazuki; Philip R Taylor; You-Lin Qiao; Sue K Park; Keun-Young Yoo; Sun Ha Jee; Eo Rin Cho; Jeongseon Kim; Sheau-Chiann Chen; Christian C Abnet; Shoichiro Tsugane; Qiuyin Cai; Xiao-Ou Shu; Wei Zheng; Michael Pawlita; Meira Epplein
Journal:  Int J Epidemiol       Date:  2016-05-11       Impact factor: 7.196

5.  Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men.

Authors:  Meira Epplein; Wei Zheng; Yong-Bing Xiang; Richard M Peek; Honglan Li; Pelayo Correa; Jing Gao; Angelika Michel; Michael Pawlita; Qiuyin Cai; Xiao-Ou Shu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10-03       Impact factor: 4.254

6.  Soy food intake and circulating levels of inflammatory markers in Chinese women.

Authors:  Sheng Hui Wu; Xiao Ou Shu; Wong-Ho Chow; Yong-Bing Xiang; Xianglan Zhang; Hong-Lan Li; Qiuyin Cai; Bu-Tian Ji; Hui Cai; Nathaniel Rothman; Yu-Tang Gao; Wei Zheng; Gong Yang
Journal:  J Acad Nutr Diet       Date:  2012-07       Impact factor: 4.910

7.  Intake of specific nonfermented soy foods may be inversely associated with risk of distal gastric cancer in a Chinese population.

Authors:  Sun-Seog Kweon; Xiao-Ou Shu; Yongbing Xiang; Hui Cai; Gong Yang; Bu-Tian Ji; Honglan Li; Yu-Tang Gao; Wei Zheng; Meira Epplein
Journal:  J Nutr       Date:  2013-08-28       Impact factor: 4.798

8.  One-carbon metabolism dietary factors and distal gastric cancer risk in chinese women.

Authors:  Sun-Seog Kweon; Xiao-Ou Shu; Yongbing Xiang; Gong Yang; Bu-Tian Ji; Honglan Li; Yu-Tang Gao; Wei Zheng; Martha J Shrubsole
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-04-30       Impact factor: 4.254

9.  Overexpression of E2F mRNAs associated with gastric cancer progression identified by the transcription factor and miRNA co-regulatory network analysis.

Authors:  XiaoTian Zhang; ZhaoHui Ni; ZiPeng Duan; ZhuoYuan Xin; HuaiDong Wang; JiaYi Tan; GuoQing Wang; Fan Li
Journal:  PLoS One       Date:  2015-02-03       Impact factor: 3.240

Review 10.  Helicobacter pylori Infection Synergistic with IL-1β Gene Polymorphisms Potentially Contributes to the Carcinogenesis of Gastric Cancer.

Authors:  Jun-Bo Hong; Wei Zuo; An-Jiang Wang; Nong-Hua Lu
Journal:  Int J Med Sci       Date:  2016-04-08       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.